HIV vaccine trial to take place in South Africa
by Press Release from Outbreak News Today on (#2396S)
The first HIV vaccine efficacy study to launch anywhere in seven years is now testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults. The study, called HVTN 702, involves a new version of the only HIV vaccine candidate ever shown to provide some protection against the virus. HVTN 702 aims ["]
The post HIV vaccine trial to take place in South Africa appeared first on Outbreak News Today.